Ratings by Morgan Stanley (David Lebowitz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2022 | Ascendis Pharma | ASND | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/7/2022 | Ascendis Pharma | ASND | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2022 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/19/2021 | Ascendis Pharma | ASND | Maintain | Overweight (N/A) |
|
Details | ||
| 11/19/2021 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2021 | Akebia Therapeutics | AKBA | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 11/5/2021 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/12/2021 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/12/2021 | Karyopharm Therapeutics | KPTI | Maintain | Overweight (N/A) |
|
Details | ||
| 10/12/2021 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/12/2021 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (N/A) |
|
Details | ||
| 10/12/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/12/2021 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/1/2021 | Schrodinger | SDGR | Upgrade | Overweight (Equalweight) |
58.71 (14.93) |
-74.57% | Details | |
| 8/24/2021 | Immuneering Corporation | IMRX | New Coverage | Equalweight (N/A) |
30.43 (4.55) |
-85.05% | Details | |
| 8/10/2021 | Epizyme | EPZM | Downgrade | Underweight (Equalweight) |
6.47 (1.47) |
-77.28% | Details | |
| 8/4/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/16/2021 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/16/2021 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (N/A) |
|
Details | ||
| 7/16/2021 | Arcutis Biotherapeutics Inc. | ARQT | Maintain | Overweight (N/A) |
|
Details | ||
| 7/16/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/16/2021 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/14/2021 | Ascendis Pharma | ASND | Maintain | Overweight (N/A) |
|
Details | ||
| 5/28/2021 | Ascendis Pharma | ASND | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/27/2021 | Arcutis Biotherapeutics Inc. | ARQT | New Coverage | Overweight (N/A) |
25.14 (13.76) |
-45.27% | Details | |
| 5/14/2021 | Avrobio Inc. | AVRO | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/12/2021 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 5/6/2021 | Epizyme | EPZM | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/6/2021 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (Underweight) |
|
Details | ||
| 4/30/2021 | MacroGenics | MGNX | Maintain | Underweight (N/A) |
|
Details | ||
| 4/30/2021 | Blueprint Medicines | BPMC | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/30/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (Underweight) |
|
Details | ||
| 3/12/2021 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/2/2021 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/26/2021 | MacroGenics | MGNX | Maintain | Underweight (Underweight) |
|
Details | ||
| 2/25/2021 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (Underweight) |
|
Details | ||
| 2/25/2021 | Epizyme | EPZM | Downgrade | Equalweight (Overweight) |
10.41 (6.47) |
-37.85% | Details | |
| 2/19/2021 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/18/2021 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/18/2021 | Blueprint Medicines | BPMC | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/12/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/4/2021 | GW Pharma | GWPH | Downgrade | Equalweight (Overweight) |
146.25 (218.96) |
49.72% | Details | |
| 12/7/2020 | Nabriva Therapeutics AG | NBRV | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/7/2020 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/30/2020 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/25/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2020 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/3/2020 | Karyopharm Therapeutics | KPTI | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2020 | Blueprint Medicines | BPMC | Downgrade | Equalweight (Overweight) |
104.63 (129.46) |
23.73% | Details | |
| 9/4/2020 | Akebia Therapeutics | AKBA | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/14/2020 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2020 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (N/A) |
|
Details | ||
| 7/15/2020 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2020 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2020 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (N/A) |
|
Details | ||
| 7/15/2020 | Blueprint Medicines | BPMC | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2020 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2020 | Akebia Therapeutics | AKBA | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/2/2020 | Karyopharm Therapeutics | KPTI | New Coverage | Overweight (N/A) |
18.94 (9.00) |
-52.48% | Details | |
| 5/29/2020 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/21/2020 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2020 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2020 | Ionis Pharmaceuticals | IONS | Maintain | Underweight (N/A) |
|
Details | ||
| 5/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2020 | Akebia Therapeutics | AKBA | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/30/2020 | Blueprint Medicines | BPMC | Maintain | Overweight (N/A) |
|
Details | ||
| 3/31/2020 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/31/2020 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/17/2020 | Nabriva Therapeutics AG | NBRV | New Coverage | Equalweight (N/A) |
0.58 (1.42) |
144.83% | Details | |
| 3/11/2020 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/11/2020 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2020 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2020 | Blueprint Medicines | BPMC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/12/2020 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/7/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/17/2020 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/17/2019 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/17/2019 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/17/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/17/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/6/2019 | Epizyme | EPZM | Upgrade | Overweight (Equalweight) |
15.81 (1.47) |
-90.7% | Details | |
| 11/21/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/21/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/21/2019 | MacroGenics | MGNX | Downgrade | Underweight (Equalweight) |
8.67 (4.20) |
-51.56% | Details | |
| 11/11/2019 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2019 | Ionis Pharmaceuticals | IONS | Downgrade | Underweight (Equalweight) |
54.39 (73.82) |
35.72% | Details | |
| 11/6/2019 | Blueprint Medicines | BPMC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/11/2019 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/11/2019 | Blueprint Medicines | BPMC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2019 | Zealand Pharma A/S | ZEAL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2019 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2019 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/6/2019 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2019 | Blueprint Medicines | BPMC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2019 | Rhythm Pharmaceuticals | RYTM | Maintain | Overweight (N/A) |
|
Details | ||
| 5/13/2019 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/3/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/2/2019 | Nabriva Therapeutics AG | NBRV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/2/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Overweight (N/A) |
|
Details | ||
| 4/3/2019 | Blueprint Medicines | BPMC | New Coverage | Overweight (N/A) |
81.03 (129.46) |
59.77% | Details | |
| 3/27/2019 | Ironwood Pharmaceuticals | IRWD | Upgrade | Equalweight (Underweight) |
13.75 (3.24) |
-76.44% | Details | |
| 3/8/2019 | Syndax Pharmaceuticals | SNDX | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/5/2019 | Alnylam Pharmaceuticals | ALNY | Upgrade | Overweight (Equalweight) |
85.37 (292.58) |
242.72% | Details | |
| 3/1/2019 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/27/2019 | Epizyme | EPZM | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/14/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Underweight (N/A) |
|
Details | ||
| 1/30/2019 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/7/2018 | Ironwood Pharmaceuticals | IRWD | Maintain | Underweight (N/A) |
|
Details | ||
| 11/7/2018 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/5/2018 | Epizyme | EPZM | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/29/2018 | Syndax Pharmaceuticals | SNDX | Downgrade | Equalweight (Overweight) |
6.04 (18.34) |
203.64% | Details | |
| 10/24/2018 | Clementia Pharmaceuticals Inc. | CMTA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/11/2018 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/28/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/28/2018 | GW Pharma | GWPH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/12/2018 | Zealand Pharma A/S | ZEAL | New Coverage | Overweight (N/A) |
17.21 (17.59) |
2.21% | Details | |
| 9/7/2018 | Rhythm Pharmaceuticals | RYTM | New Coverage | Overweight (N/A) |
31.50 (84.71) |
168.92% | Details | |
| 9/7/2018 | Nabriva Therapeutics AG | NBRV | New Coverage | Overweight (N/A) |
2.62 (1.42) |
-45.8% | Details | |
| 9/7/2018 | Akebia Therapeutics | AKBA | New Coverage | Equalweight (N/A) |
8.16 (0.97) |
-88.11% | Details | |
| 9/7/2018 | Epizyme | EPZM | New Coverage | Equalweight (N/A) |
10.65 (15.81) |
48.45% | Details | |
| 9/7/2018 | GW Pharma | GWPH | New Coverage | Overweight (N/A) |
144.82 (218.96) |
51.19% | Details | |
| 8/28/2018 | Ionis Pharmaceuticals | IONS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/13/2018 | Clementia Pharmaceuticals Inc. | CMTA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2018 | Avrobio Inc. | AVRO | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2018 | Alnylam Pharmaceuticals | ALNY | Maintain | Equalweight (N/A) |
|
Details |
